LGD-4033
For Sale
Ligandrol
LGD-4033 (Ligandrol, VK5211) — the most potent non-steroidal SARM in lean mass preclinical research. Independently tested to ≥99% purity via HPLC and Mass Spectrometry. Available in liquid, powder, and capsules. Free shipping over $100.
Third-Party COA
USA Manufactured
HPLC + Mass Spec Tested
Free Shipping $100+
Ships Same Day
Research Compound Overview
What Is LGD-4033? The Most Potent SARM for Lean Mass Research
LGD-4033 (Ligandrol, VK5211) is a non-steroidal selective androgen receptor modulator (SARM) originally developed by Ligand Pharmaceuticals and later licensed to Viking Therapeutics. It is widely recognized as the most potent lean-mass SARM in preclinical research, producing the strongest anabolic signal in muscle tissue among all non-steroidal SARMs studied to date.
When you buy LGD-4033 for sale from PureRawz, every batch is independently verified to ≥99% purity via HPLC and Mass Spectrometry by MZ Biolabs — a third-party accredited laboratory. Every Certificate of Analysis is published publicly and searchable by batch lot number.
In direct comparative animal model studies, LGD-4033 produces greater anabolic activity in skeletal muscle at lower doses than any other non-steroidal SARM. Phase I clinical trial data confirmed significant lean body mass increases at doses as low as 1mg/day in healthy men — the strongest effect-per-dose ratio documented in SARM clinical research to date.
LGD-4033 Product Specifications
| Compound Name | LGD-4033 (Ligandrol, VK5211, SARM-0501) |
| Class | Selective Androgen Receptor Modulator (SARM) |
| Molecular Formula | C₁₄H₁₂F₆N₂O |
| Molecular Weight | 338.25 g/mol |
| CAS Number | 1165910-22-4 |
| Purity (PureRawz) | ≥99% HPLC verified |
| Testing Lab | MZ Biolabs (independent, third-party) |
| Half-Life (animal) | ~24–36 hours (oral) |
| Available Forms | Liquid · Capsules · Powder |
| Intended Use | Research purposes only — not for human use |
Available Formats
LGD-4033 For Sale in Multiple Research Forms
PureRawz offers LGD-4033 in three delivery formats. All forms use the same ≥99% purity compound with batch-specific third-party COA documentation.
Pre-suspended LGD-4033 in carrier solution at a precise concentration. Ready for immediate research use — no reconstitution required. Available in 30ml and 60ml amber glass vials with calibrated dropper for accurate dosing across protocols.
Pre-measured oral capsules delivering a consistent, exact dose per serving. Preferred for long-duration research protocols where daily dosing consistency is critical for reproducible results.
Pure LGD-4033 powder for researchers who require custom concentrations or novel formulations. Best cost-per-milligram ratio. Available in 1g and bulk 5g quantities for extended research programs.
SARM Comparison
LGD-4033 vs Other SARMs — How Does Ligandrol Compare?
LGD-4033 is most frequently compared to RAD 140 and Ostarine in research literature. The table below highlights key distinctions based on published preclinical and clinical data.
| Factor | LGD-4033 | RAD 140 | Ostarine MK-2866 | YK-11 |
|---|---|---|---|---|
| Anabolic Potency | Highest (SARM) | Very High | Moderate | Very High |
| Selectivity | Moderate–High | High | Very High | Moderate |
| Clinical Trial Data | Phase I (human) | Phase I | Phase II / III | Preclinical only |
| Lean Mass Research | Strongest signal | Very strong | Moderate | Strong |
| Bone Density Research | Yes — VK5211 | Yes | Yes | Limited |
| Neuroprotective Data | Limited | Yes | Limited | Limited |
| PureRawz Price | From $29.99 | From $29.99 | From $29.99 | From $34.99 |
All data reflects preclinical animal model and early clinical findings only. Not applicable to human use.
Why PureRawz
Why Researchers Buy LGD-4033 From PureRawz
LGD-4033’s potency makes it a high-demand product — and a high-counterfeiting target. PureRawz eliminates uncertainty with three non-negotiable standards.
Every LGD-4033 batch is tested by MZ Biolabs — accredited, independent, third-party. The COA is published publicly on every product page, searchable by lot number. No exceptions, no generic documents.
HPLC and Mass Spectrometry confirm purity and compound identity on every batch. Full impurity profiles documented. LGD-4033’s potency advantage is only valid when purity is verified — a low-purity vial means an unknowable dose.
Manufactured and fulfilled from a US facility. Orders before 2PM EST ship same business day. Domestic delivery in 2–4 business days. Discreet, unmarked packaging on every single order.
LGD-4033 is one of the most counterfeited SARMs on the market. Its potency and demand make it a prime target for underdosed products. A COA from an independent laboratory — not a vendor’s in-house document — is the only verification that matters. PureRawz publishes every COA, every batch, searchable by lot number on every product page.
Preclinical & Clinical Research Overview
LGD-4033 Research: What the Data Shows
LGD-4033 has one of the most compelling research profiles of any SARM — combining strong preclinical data with published Phase I human clinical trial results. The following summarizes primary research directions. All data reflects animal model and early clinical findings. LGD-4033 is not FDA-approved.
Primary Research Areas
-
Lean Body Mass (Phase I Clinical): A Phase I clinical trial in healthy male volunteers demonstrated statistically significant dose-dependent increases in lean body mass at doses of 0.1mg–1mg/day over 21 days — with the strongest lean mass signal of any SARM tested in human trials to date.
-
Muscle Wasting & Cachexia: Preclinical rodent studies show LGD-4033 produces potent anabolic effects in muscle tissue at very low doses, with reduced androgenic activity outside muscle and bone — positioning it as a top candidate for cachexia and sarcopenia research.
-
Bone Density — VK5211 Program: Viking Therapeutics licensed LGD-4033 as VK5211 and has conducted hip fracture rehabilitation studies, with Phase II data showing improved lean mass and functional outcomes in fracture recovery — one of the most advanced clinical applications of any SARM.
-
Stair Climb & Physical Function: Phase I and VK5211 trial data examined functional performance endpoints including stair climb power — demonstrating improvements in physical function alongside lean mass gains in clinical subjects.
-
Hormonal Research: LGD-4033 binds selectively to androgen receptors in muscle and bone with reduced prostate activity in animal models. Testosterone suppression has been observed in Phase I data — an important variable in research protocol design.
-
Body Composition Remodeling: Phase I data demonstrated reductions in body fat percentage concurrent with lean mass increases at higher doses — making LGD-4033 a focus of body composition research in elderly and clinical populations.
LGD-4033 Legal Status in 2026
LGD-4033 is legal to purchase in the United States as a research compound. It is not a controlled substance, not scheduled under the DEA, and does not require a prescription when purchased strictly for laboratory research purposes. PureRawz sells LGD-4033 in full regulatory compliance — labeled for research use only, not for human or animal consumption.
Research Reference
LGD-4033 Research Dosage Reference — Preclinical & Clinical Data Only
The following summarizes dosage ranges reported in published preclinical and clinical research. Provided for reference only. Not a recommendation for human use.
| Research Protocol | Reported Dose | Route | Duration (Studies) |
|---|---|---|---|
| Lean Mass (Phase I human) | 0.1–1 mg/day | Oral | 21 days |
| Muscle Tissue (rodent) | 0.04–1 mg/kg/day | Oral gavage | 7–28 days |
| Bone / Hip Fracture (VK5211) | 1–2 mg/day | Oral | 12 weeks |
| Body Composition Research | 0.1–1 mg/day (Phase I) | Oral | 21 days |
| Muscle Wasting / Sarcopenia | 0.1–3 mg/kg/day (rodent) | Oral gavage | 14–56 days |
Data sourced from peer-reviewed preclinical and Phase I/II clinical literature. LGD-4033 is not FDA-approved. Human use is not endorsed or recommended.
Frequently Asked Questions
LGD-4033 For Sale — Buyer FAQs
Reviews
There are no reviews yet.